Home/Filings/4/0001593968-22-000636
4//SEC Filing

Vanhove Geertrui 4

Accession 0001593968-22-000636

CIK 0001824893other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:54 PM ET

Size

5.5 KB

Accession

0001593968-22-000636

Insider Transaction Report

Form 4
Period: 2022-03-01
Vanhove Geertrui
Chief Medical Officer
Transactions
  • Award

    Option Grant (right to buy)

    2022-03-01$3.11/sh+125,000$388,750125,000 total
    Exercise: $3.11From: 2022-02-01Exp: 2032-03-01Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2022, subject to the reporting person's continued employment through the applicable vesting date.

Issuer

Surrozen, Inc./DE

CIK 0001824893

Entity typeother

Related Parties

1
  • filerCIK 0001771994

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:54 PM ET
Size
5.5 KB